- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/22 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Neisseriaceae (F), e.g. Acinetobacter
Patent holdings for IPC class C07K 14/22
Total number of patents in this class: 308
10-year publication summary
|
27
|
16
|
30
|
24
|
21
|
19
|
18
|
14
|
14
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1653 |
56 |
| Pfizer Inc. | 3368 |
34 |
| The Regents of the University of California | 19989 |
19 |
| Aridis Pharmaceuticals Inc. | 26 |
10 |
| Wyeth LLC | 659 |
8 |
| Children's Hospital & Research Center at Oakland | 61 |
8 |
| Wyeth Holdings LLC | 54 |
7 |
| Novartis AG | 10741 |
6 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 370 |
5 |
| Oxford University Innovation Limited | 1541 |
5 |
| Engineered Antigens Inc. | 12 |
5 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2166 |
4 |
| MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. | 23 |
4 |
| Sanofi Pasteur Inc. | 363 |
4 |
| Serum Institute of India Private Limited | 100 |
4 |
| T2 Biosystems, Inc. | 118 |
4 |
| University of Massachusetts | 2229 |
4 |
| Cansino Biologics Inc. | 75 |
4 |
| The Board of Trustees of the University of Illinois | 2702 |
3 |
| Asociación Centro de Investigación Cooperativa en Biociencias-cic Biogune | 47 |
3 |
| Other owners | 111 |